Home

Starai meglio Solito ascia gabriella farina fatebenefratelli cantante fuga portatile

Italian Nivolumab Expanded Access Program in Nonsquamous Non–Small Cell  Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients -  Journal of Thoracic Oncology
Italian Nivolumab Expanded Access Program in Nonsquamous Non–Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients - Journal of Thoracic Oncology

The prognostic role of tumor size in early breast cancer in the era of  molecular biology | PLOS ONE
The prognostic role of tumor size in early breast cancer in the era of molecular biology | PLOS ONE

Diapositiva 1
Diapositiva 1

FORMATO EUROPEO PER IL CURRICULUM VITAE
FORMATO EUROPEO PER IL CURRICULUM VITAE

Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised  study by the Italian Trials in Medical Oncology (ITMO) Group - Annals of  Oncology
Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group - Annals of Oncology

ASST Fatebenefratelli & SACCO | ESMO
ASST Fatebenefratelli & SACCO | ESMO

Nutritional Support in Cancer patients: update of the Italian Intersociety  Working Group practical recommendations
Nutritional Support in Cancer patients: update of the Italian Intersociety Working Group practical recommendations

20+ "Gabriella Farina" profiles | LinkedIn
20+ "Gabriella Farina" profiles | LinkedIn

Gabriella Farina's research works | Azienda Ospedaliera Fatebenefratelli e  Oftalmico Milano (Fatebenefratelli) and other places
Gabriella Farina's research works | Azienda Ospedaliera Fatebenefratelli e Oftalmico Milano (Fatebenefratelli) and other places

Rationale for Treatment and Study Design of TAILOR: A Randomized Phase III  Trial of Second-line Erlotinib Versus Docetaxel in the Treatment of  Patients Affected by Advanced Non–Small-Cell Lung Cancer With the Absence
Rationale for Treatment and Study Design of TAILOR: A Randomized Phase III Trial of Second-line Erlotinib Versus Docetaxel in the Treatment of Patients Affected by Advanced Non–Small-Cell Lung Cancer With the Absence

Randomised Phase II Trial (NCT00637975) Evaluating Activity and Toxicity of  Two Different Escalating Strategies for Pregabalin and Oxycodone  Combination Therapy for Neuropathic Pain in Cancer Patients | PLOS ONE
Randomised Phase II Trial (NCT00637975) Evaluating Activity and Toxicity of Two Different Escalating Strategies for Pregabalin and Oxycodone Combination Therapy for Neuropathic Pain in Cancer Patients | PLOS ONE

Il caregiver in oncologia: una guida per sostenere il malato | Fondazione  Aiom
Il caregiver in oncologia: una guida per sostenere il malato | Fondazione Aiom

Gabriella Farina's research works | Azienda Ospedaliera Fatebenefratelli e  Oftalmico Milano (Fatebenefratelli) and other places
Gabriella Farina's research works | Azienda Ospedaliera Fatebenefratelli e Oftalmico Milano (Fatebenefratelli) and other places

Overall Survival in Metastatic Breast Cancer Patients in the Third  Millennium: Results of the COSMO Study∗ - Clinical Breast Cancer
Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study∗ - Clinical Breast Cancer

La Rete locale di Cure Palliative di Milano
La Rete locale di Cure Palliative di Milano

20+ "Gabriella Farina" profiles | LinkedIn
20+ "Gabriella Farina" profiles | LinkedIn

Gabriella e la squadra con 70 donne «La nostra sfida ai tumori» -  Corriere.it
Gabriella e la squadra con 70 donne «La nostra sfida ai tumori» - Corriere.it

Nutrients | Free Full-Text | The Role of Nutritional Support for Cancer  Patients in Palliative Care | HTML
Nutrients | Free Full-Text | The Role of Nutritional Support for Cancer Patients in Palliative Care | HTML

LKB1 mutations are not associated with the efficacy of first-line and  second-line chemotherapy in patients with advanced non-small-cell lung  cancer (NSCLC): a post hoc analysis of the TAILOR trial - ESMO Open
LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial - ESMO Open

Nutrients | Free Full-Text | The Clinical Value of Nutritional Care before  and during Active Cancer Treatment | HTML
Nutrients | Free Full-Text | The Clinical Value of Nutritional Care before and during Active Cancer Treatment | HTML

Presentazione standard di PowerPoint
Presentazione standard di PowerPoint

Awareness and consideration of malnutrition among oncologists: Insights  from an exploratory survey
Awareness and consideration of malnutrition among oncologists: Insights from an exploratory survey

Prospective observational study on the impact of the 21-gene assay on  treatment decisions and resources optimization in breast cancer patients in  Lombardy: The BONDX study - The Breast
Prospective observational study on the impact of the 21-gene assay on treatment decisions and resources optimization in breast cancer patients in Lombardy: The BONDX study - The Breast

Sabato 7 Aprile corso Unitalsi: "la fine della vita" - CiaoComo
Sabato 7 Aprile corso Unitalsi: "la fine della vita" - CiaoComo

Multicenter, randomised, open-label, non-comparative phase 2 trial on the  efficacy and safety of the combination of bevacizumab and trabectedin with  or without carboplatin in women with partially platinum-sensitive recurrent  ovarian cancer
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer